Robert Goeltz
Director of Finance/CFO at ARCUS BIOSCIENCES, INC.
Net worth: 227 667 $ as of 29/04/2024
Robert Goeltz active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ARCUS BIOSCIENCES, INC. | Director of Finance/CFO | 31/07/2020 | - |
| Comptroller/Controller/Auditor | 31/07/2020 | 08/03/2023 |
Career history of Robert Goeltz
Former positions of Robert Goeltz
| Companies | Position | Start | End |
|---|---|---|---|
| UNITY BIOTECHNOLOGY, INC. | Director of Finance/CFO | 31/08/2017 | 31/07/2020 |
| CYTOMX THERAPEUTICS, INC. | Director of Finance/CFO | 26/05/2015 | 14/05/2017 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Director of Finance/CFO | 30/09/2013 | 30/04/2015 |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Director of Finance/CFO | 30/06/2002 | 31/07/2004 |
Training of Robert Goeltz
| UCLA Anderson School of Management | Masters Business Admin |
| Goizueta Business School-Emory | Undergraduate Degree |
Statistics
International
| United States | 8 |
Operational
| Director of Finance/CFO | 5 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| CYTOMX THERAPEUTICS, INC. | Health Technology |
| UNITY BIOTECHNOLOGY, INC. | Health Technology |
| ARCUS BIOSCIENCES, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
- Stock Market
- Insiders
- Robert Goeltz
- Experience
